TITLE

PET/CT SUV of Prognostic Value in Metastatic Breast Cancer

AUTHOR(S)
Ershler, William B.
PUB. DATE
December 2012
SOURCE
Clinical Oncology Alert;Dec2012, Vol. 28 Issue 12, p90
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The author comments on a study by P. G. Morris and colleagues, which found that the fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT)-derived standardized uptake value (SUV) offered prognostic information, and those with high levels of FDG uptake and had shorter survival than those with low levels. He suggests the clinicians to be aware of SUV levels, within bone metastatic bone cancer (MBC) lesions, which may indicate aggressive disease.
ACCESSION #
83731354

 

Related Articles

  • Study Supports PET/CT Staging for Breast Cancer.  // Radiology Today;Feb2013, Vol. 14 Issue 2, p38 

    The article presents information on a study conducted by David Groheux and his team at Saint Louis Hospital in Paris, France, according to which the use of 18F-FDG PET/CT scan for initial staging provides significant prognostic information for patients suffering from locally advanced breast...

  • Clinical utility of positron emission mammography. Glass, Shannon B.; Shah, Zeeshan A. // Baylor University Medical Center Proceedings;Jul2013, Vol. 26 Issue 3, p314 

    Several imaging modalities have been introduced over recent years to better screen for and stage breast cancer. Positron emission mammography (PEM) has been approved by the US Food and Drug Administration and introduced into clinical use as a diagnostic adjunct to mammography and breast...

  • The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Luminari, S.; Biasoli, I.; Arcaini, L.; Versari, A.; Rusconi, C.; Merli, F.; Spina, M.; Ferreri, A. J. M.; Zinzani, P. L.; Gallamini, A.; Mastronardi, S.; Boccomini, C.; Gaidano, G.; D'Arco, A. M.; Di Raimondo, F.; Carella, A. M.; Santoro, A.; Musto, P.; Federico, M. // Annals of Oncology;Aug2013, Vol. 24 Issue 8, p2108 

    Background The role of [18F] fluorodeoxyglucose (FDG)-positron emission tomography (PET) in follicular lymphoma (FL) staging is not yet determined. Patients and methods The aim of the present study was to investigate the role of PET in the initial staging of FL patients enrolled in the...

  • Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma. Tsutani, Y.; Miyata, Y.; Nakayama, H.; Okumura, S.; Adachi, S.; Yoshimura, M.; Okada, M. // Annals of Oncology;Sep2013, Vol. 24 Issue 9, p2376 

    Background To better describe clinical T descriptors using solid tumor size (the maximum dimension of the solid component of the tumor) on high-resolution computed tomography (HRCT) and maximum standardized uptake value (SUVmax) on F-18-fluorodeoxyglucose positron emission tomography/CT...

  • New trends for staging and therapy for localized gastroesophageal cancer: the role of PET. Lordick, F.; Ott, K.; Krause, B. J. // Annals of Oncology;Oct2010 Supplement 7, Vol. 21 Issue suppl_7, pvii294 

    Treatment options for localized gastroesophageal cancers reach from limited resection to multimodality treatment. Accurate clinical assessment, prognostic and predictive information are needed to select the most appropriate treatment approach. Positron emission tomography (PET) in combination...

  • Uterine Cervical Cancer Metastases to Mediastinal Lymph Nodes Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Aspiration. Krishna, Somashekar G.; Ghouri, Yezaz A.; Suzuki, Rei; Bhutani, Manoop S. // Endoscopic Ultrasound;Nov2013, Vol. 2 Issue 4, p219 

    A case study of a 35-year-old Asian female patient who was admitted for irregular menstrual bleeding and diagnosed with moderately differentiated squamous cell cervical carcinoma. Topics discussed include referring of woman to a tertiary cancer center for continued management, using endoscopic...

  • PET/CT in renal and bladder cancers. Balenović, Antonija; Mihailović, Jasna; Jazvić, Marijana; Tabain, Anita; Grbac-Ivanković, Svjetlana // Archive of Oncology;2013, Vol. 21 Issue 2, p97 

    FDG is the most frequently used positron emission tomography probe but it has certain limitations when used in urological cancers due to its urinary elimination, which prevents the proper visualization of the bladder and kidneys. The introduction of co-registered PET and computed tomography...

  • Quality study of a lung cancer committee: study of agreement between preoperative and pathological staging Macia, Ivan; Moya, Juan; Escobar, Ignacio; Ramos, Ricard; Masuet, Cristina; Gamez, Cristina; Llatjos, Roger; Martinez-Ballarin, Ignacio // European Journal of Cardio-Thoracic Surgery;Mar2010, Vol. 37 Issue 3, p540 

    Abstract: Objective: Accurate preoperative staging is essential to provide the best treatment for lung cancer. The objective of the present study was to determine agreement between preoperative and surgical–pathological staging and to analyse the impact of any disparity on treatment....

  • Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer. Culverwell, A.; Chowdhury, F.; Scarsbrook, A. // Abdominal Imaging;Dec2012, Vol. 37 Issue 6, p1021 

    Recent treatment advances now allow a realistic chance of cure in selected patients with metastatic colorectal carcinoma (CRC). Accurate pre-treatment staging is crucial to ensure appropriate management by identification of patients with more advanced disease who will not benefit from surgery....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics